NPI: 1700975927 · EL MONTE, CA 91732 · Community Health Clinic/Center · NPI assigned 10/12/2006
Authorized official PAHL, LINDA controls 20+ related entities in our dataset. Read more
| Authorized Official | PAHL, LINDA (CFO) |
| NPI Enumeration Date | 10/12/2006 |
Other providers sharing the same authorized official: PAHL, LINDA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 21,992 | $1.01M |
| 2019 | 12,267 | $568K |
| 2020 | 9,381 | $326K |
| 2021 | 14,491 | $498K |
| 2022 | 10,918 | $418K |
| 2023 | 11,452 | $487K |
| 2024 | 10,562 | $449K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J3490 | Unclassified drugs | 14,894 | 12,461 | $516K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 8,708 | 7,820 | $506K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3,622 | 3,382 | $491K |
| S4993 | Contraceptive pills for birth control | 3,527 | 3,517 | $348K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3,480 | 3,334 | $347K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 881 | 865 | $284K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1,005 | 953 | $213K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 957 | 952 | $186K |
| 99201 | 1,375 | 1,250 | $170K | |
| 87806 | 6,309 | 4,797 | $158K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 184 | 184 | $155K |
| A4267 | Contraceptive supply, condom, male, each | 11,572 | 11,312 | $65K |
| 11981 | 184 | 184 | $41K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | 2,715 | 2,715 | $34K |
| 81025 | 11,050 | 10,649 | $34K | |
| 99401 | 1,148 | 1,140 | $22K | |
| S5000 | Prescription drug, generic | 2,991 | 2,839 | $21K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 52 | 52 | $21K |
| 57454 | 303 | 152 | $18K | |
| 58300 | 183 | 91 | $17K | |
| 99000 | 4,628 | 4,593 | $16K | |
| J7304 | Contraceptive supply, hormone containing patch, each | 54 | 54 | $15K |
| J7303 | Contraceptive supply, hormone containing vaginal ring, each | 182 | 182 | $14K |
| 83986 | 4,129 | 3,328 | $11K | |
| 99402 | 324 | 324 | $10K | |
| Q0111 | Wet mounts, including preparations of vaginal, cervical or skin specimens | 2,676 | 2,625 | $10K |
| 11976 | 132 | 69 | $7K | |
| 86703 | 518 | 411 | $5K | |
| Q0144 | Azithromycin dihydrate, oral, capsules/powder, 1 gram | 967 | 945 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 303 | 288 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 304 | 289 | $3K |
| 58301 | 78 | 41 | $2K | |
| 81002 | 1,265 | 1,241 | $2K | |
| 86592 | 271 | 270 | $661.53 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 80 | 76 | $406.76 |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 12 | 12 | $182.34 |